Get started
Author

Jayesh Sanmukhani

Observed name: Jayesh J. Sanmukhani
ORCID: 0000-0003-4663-4431
Observed ORCID: 0000-0003-4663-4431
OpenAlex ID: A5086793559
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
2022 · Akash Khobragade, Suresh Bhate, et al. · The Lancet · 262
PDF
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
2021 · Taufik Momin, Kevinkumar Kansagra, et al. · EClinicalMedicine · 186
PDF
Efficacy and safety of avanafil as compared with sildenafil in the treatment of erectile dysfunction: A randomized, double blind, multicenter clinical trial
2022 · Manish Kumar, Amey D Pathade, et al. · International Journal of Urology · 24
PDF
Efficacy and Safety of Fluticasone Furoate and Oxymetazoline Nasal Spray: A Novel First Fixed Dose Combination for the Management of Allergic Rhinitis with Nasal Congestion
2022 · RS Kumar, Manish Kumar Jain, et al. · Journal of Asthma and Allergy · 21
PDF
Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial
2017 · Ashwani Sood, Monjori Mitra, et al. · Human Vaccines & Immunotherapeutics · 15
Adverse drug reaction profile of oseltamivir in Indian population: A prospective observational study
2011 · Ashish P. Anovadiya, Manish J. Barvaliya, et al. · Indian Journal of Pharmacology · 10
PDF
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial
2018 · Shrikant Sharma, Veer Bahadur Singh, et al. · Human Vaccines & Immunotherapeutics · 9
PDF
Ramosetron hydrochloride for the prevention of cancer chemotherapy induced nausea and vomiting: The Indian experience
2014 · Jayesh J. Sanmukhani, Prafulla Pawar, et al. · South Asian Journal of Cancer · 8
PDF
A prospective, randomized, parallel, active controlled, phase III Indian study of immunogenicity and safety of two inactivated influenza vaccines - Vaxiflu-4 and Fluarix tetra in children aged 6 months to 35 months
2024 · Kairav Kothari, Shreyansh Shah, et al. · Human Vaccines & Immunotherapeutics · 6
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial
2020 · Sumantra Sarkar, Chandrakant Bokade, et al. · Human Vaccines & Immunotherapeutics · 4
Immunogenicity and Safety of a Novel MMR Vaccine (Live) (Freeze-dried): Results of a Phase II Clinical Trial
2018 · Rajesh Joshi, Neeta Hanumante, et al. · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · 1
Works count: 11
Citation count: 546
H-index: 8
I10-index: 6
Year
Topic
Type